GlassScriptPhysician profile
Melissa M D Hill
NPI 1902246309
$1,407.14
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $215 · 2020: $101 · 2021: $203 · 2022: $137 · 2023: $351 · 2024: $401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $751.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $258.90 | 2022-2024 | Qelbree, Qelbree |
| Glaxosmithkline, LLC. | $181.40 | 2020-2024 | Pediarix, Bexsero, Menveo |
| Ultragenyx Pharmaceutical INC. | $154.18 | 2021-2024 | Crysvita |
| Gilead Sciences, INC. | $119.60 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $106.16 | 2022-2024 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Ironshore Pharmaceuticals INC. | $88.16 | 2022-2024 | Jornay Pm |
| Almatica Pharma LLC | $77.78 | 2022-2024 | Loreev Xr, Sertraline Hcl, Gralise |
| Sanofi Pasteur INC. | $70.20 | 2019-2023 | |
| Novo Nordisk INC | $54.71 | 2019-2021 | |
| Amarin Pharma, INC. | $43.98 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $42.70 | 2019 | |
| Smith+Nephew, INC. | $41.64 | 2023 | Tula |
| Philips North America LLC | $34.31 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $29.57 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $26.43 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $19.73 | 2023 | Doc Band |
| Corium, LLC | $16.49 | 2023 | Azstarys |
| Amgen INC. | $14.33 | 2019 | |
| Phadia US INC. | $13.60 | 2019 | |
| Sobi, INC | $13.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.